Literature DB >> 2104587

The paraventricular nucleus of the hypothalamus has a major role in thyroid hormone feedback regulation of thyrotropin synthesis and secretion.

T Taylor1, F E Wondisford, T Blaine, B D Weintraub.   

Abstract

The role of the hypothalamic paraventricular nucleus (PVN) in thyroid hormone regulation of TSH synthesis during hypothyroidism was studied in adult male rats that were normal (n = 10), had primary hypothyroidism with sham lesions in the hypothalamus (n = 17), and had primary hypothyroidism with PVN lesions (n = 14). Two and 4 weeks after initiation of treatment, plasma levels of thyroid hormones (TSH, corticosterone and PRL) and pituitary content of TSH beta and alpha-subunit mRNA were measured. TRH mRNA levels in the PVN were determined by in situ hybridization histochemistry. At 2 weeks, despite a decrease in plasma free T4 in both hypothyroid groups, plasma TSH levels increased, but to a lesser degree, in the hypothyroid PVN lesioned compared to hypothyroid sham-lesioned group (7.8 +/- 1.3 vs. 20.5 +/- 1.1 ng/dl; P less than 0.05). Similarly, at 4 weeks, the hypothyroid PVN-lesioned group demonstrated a blunted TSH response compared to the hypothyroid sham-lesioned group (6.8 +/- 0.7 vs. 24.0 +/- 1.3 ng/dl; P less than 0.05). Plasma corticosterone and PRL did not significantly differ between sham-lesioned and PVN-lesioned groups. TSH beta mRNA levels markedly increased in hypothyroid sham-lesioned rats compared to those in euthyroid controls at 2 weeks (476 +/- 21% vs. 100 +/- 39%; P less than 0.05) and 4 weeks (1680 +/- 270% vs. 100 +/- 35%; P less than 0.05). In contrast, TSH beta mRNA levels did not increase with hypothyroidism in the PVN-lesioned group compared to those in euthyroid controls at 2 weeks (140 +/- 16%, P = NS) and only partially increased at 4 weeks (507 +/- 135; P less than 0.05). alpha mRNA levels at 4 weeks markedly increased in hypothyroid sham-lesioned rats compared to those in euthyroid controls (1121 +/- 226% vs. 100 +/- 48%; P less than 0.05), but did not increase in the hypothyroid PVN-lesioned rats (61 +/- 15%; P = NS). TRH mRNA in the PVN increased in the hypothyroid sham-lesioned rats compared to those in euthyroid controls (16.6 +/- 1.3 vs. 4.8 +/- 1.2 arbitrary densitometric units; P less than 0.05), and TRH mRNA was not detectable in the PVN of hypothyroid-lesioned rats at 2 weeks. In summary, lesions in rat PVN prevented the full increase in plasma TSH, pituitary TSH beta mRNA, and alpha mRNA levels in response to hypothyroidism. Thus, factors in the PVN are important in thyroid hormone feedback regulation of both TSH synthesis and secretion.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2104587     DOI: 10.1210/endo-126-1-317

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  5 in total

1.  Congenital hypothyroidism (cretinism) in neuroD2-deficient mice.

Authors:  Chin-Hsing Lin; Stephen J Tapscott; James M Olson
Journal:  Mol Cell Biol       Date:  2006-06       Impact factor: 4.272

Review 2.  Multifactorial modulation of TRH metabolism.

Authors:  P Joseph-Bravo; R M Uribe; M A Vargas; L Pérez-Martínez; T Zoeller; J L Charli
Journal:  Cell Mol Neurobiol       Date:  1998-04       Impact factor: 5.046

3.  Sex differences in U50,488H-induced phosphorylation of p44/42 mitogen-activated protein kinase in the guinea pig brain.

Authors:  K Rasakham; K L McGillivray; L-Y Liu-Chen
Journal:  Neuroscience       Date:  2012-07-31       Impact factor: 3.590

4.  Iodine excess exposure during pregnancy and lactation impairs maternal thyroid function in rats.

Authors:  Caroline Serrano-Nascimento; Rafael Barrera Salgueiro; Kaio Fernando Vitzel; Thiago Pantaleão; Vânia Maria Corrêa da Costa; Maria Tereza Nunes
Journal:  Endocr Connect       Date:  2017-08-16       Impact factor: 3.335

Review 5.  Metabolic Implications of Exposure to Light at Night: Lessons from Animal and Human Studies.

Authors:  Giulia Fleury; Anayanci Masís-Vargas; Andries Kalsbeek
Journal:  Obesity (Silver Spring)       Date:  2020-07       Impact factor: 5.002

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.